Coherus BioSciences CHRS reported its Q3 earnings results on Monday, November 8, 2021 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Coherus BioSciences their estimated earnings by 54.55%, reporting an EPS of $-0.34 versus an estimate of $-0.22, which surprised analysts.
Revenue was up $31,048,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.19, which was followed by a 0.46% increase in the share price the next day.
Here's a look at Coherus BioSciences's past performance:
Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
---|---|---|---|---|
EPS Estimate | -0.17 | 0.06 | 0.23 | 0.41 |
EPS Actual | -0.36 | 0.01 | 0.23 | 0.47 |
Revenue Estimate | 89.81M | 96.00M | 115.12M | 122.88M |
Revenue Actual | 87.64M | 83.03M | 110.42M | 113.55M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.